Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ACHILLES THERAPEUTICS PLC ACHL | BAKER BROS. ADVISORS LP | 4,207,733 9.900% | 168,253 (+4.17%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BAKER BROS. ADVISORS LP | 255,361 9.900% | 53,582 (+26.55%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | BAKER BROS. ADVISORS LP | 4,954,855 8.700% | 413,251 (+9.10%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 56,482 8.000% | 4,145 (+7.92%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BIOMEA FUSION INC BMEA | BAKER BROS. ADVISORS LP | 2,104,559 7.200% | 2,104,559 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CABALETTA BIO INC CABA | BAKER BROS. ADVISORS LP | 1,344,000 5.200% | 1,344,000 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | BAKER BROS. ADVISORS LP | 2,492,118 7.000% | 2,492,118 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | IMMATICS N V IMTX | BAKER BROS. ADVISORS LP | 5,187,081 6.800% | 763,350 (+17.26%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | REPLIMUNE GROUP INC REPL | BAKER BROS. ADVISORS LP | 5,768,227 9.990% | 5,768,227 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BAKER BROS. ADVISORS LP | 6,354,608 11.300% | 291,906 (+4.81%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | INOZYME PHARMA INC INZY | BAKER BROS. ADVISORS LP | 2,168,000 5.100% | 2,168,000 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | BAKER BROS. ADVISORS LP | 2,879,825 5.200% | 2,879,825 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 4,801,954 9.990% | 2,347,872 (+95.67%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 9.000% | 45,900 (+3.06%) | Filing History |
| 2023-02-10 4:29 pm Sale | 2023-01-31 | 13G | OTONOMY INC OTIC | BAKER BROS. ADVISORS LP | 0 0.000% | -3,448,263 (Position Closed) | Filing History |
| 2023-01-17 4:32 pm Purchase | 2023-01-12 | 13D | ACADIA PHARMACEUTICALS INC ACAD | BAKER BROS. ADVISORS LP | 42,306,789 26.100% | 1,138,932 (+2.77%) | Filing History |
| 2022-12-12 4:49 pm Sale | 2022-11-30 | 13G | AMARIN CORP PLC SPONSORED ADR AMRN | BAKER BROS. ADVISORS LP | 0 0.000% | -1,064,659 (Position Closed) | Filing History |
| 2022-11-10 4:35 pm Sale | 2022-10-31 | 13G | OTONOMY INC OTIC | BAKER BROS. ADVISORS LP | 3,448,263 6.100% | -4,396,429 (-56.04%) | Filing History |
| 2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BAKER BROS. ADVISORS LP | 6,062,702 10.900% | 2,199,463 (+56.93%) | Filing History |
| 2022-07-20 5:12 pm Purchase | 2022-07-15 | 13D | IMMUNOCORE HLDGS PLC ADS IMCR | BAKER BROS. ADVISORS LP | 4,685,690 9.930% | 1,333,333 (+39.77%) | Filing History |